This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter: revenue up 16.5%, profit up 12.4%, margin widens
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended September 30, 2026: revenue from operations rose 16.5% to Rs 1,147.65 lakh from Rs 985.39 lakh a year earlier, and profit after tax rose 12.4% to Rs 67.47 lakh from Rs 60.02 lakh. EBITDA margin improved to 8.9% from 7.6%. Standalone half-year revenue was Rs 2,088.77 lakh and profit Rs 151.06 lakh. The board approved these unaudited results on November 4, 2026; auditors found no material misstatement.
Higher revenue, profit and margin may support the stock, but quarter growth stayed moderate and the company has no borrowings.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹11.48 Cr | ₹9.85 Cr | +16.5% |
| Operating profit | ₹0.84 Cr | ₹0.60 Cr | +38.8% |
| Profit after tax | ₹0.67 Cr | ₹0.60 Cr | +12.4% |
| EBITDA margin | 8.8% | 7.6% | +1.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.